• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组表达微阵列结合机器学习识别高级别神经胶质瘤的预后生物标志物。

Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma.

机构信息

School of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, China.

Tianjin Cerebral Vascular and Neural Degenerative Disease Key Laboratory, Tianjin Neurosurgery Institute, Tianjin Huan Hu Hospital, Tianjin, 300100, China.

出版信息

J Mol Neurosci. 2018 Apr;64(4):491-500. doi: 10.1007/s12031-018-1049-7. Epub 2018 Mar 3.

DOI:10.1007/s12031-018-1049-7
PMID:29502292
Abstract

The aim of our study is to build a framework for a better understanding of high-grade glioma (HGG) prognostic-related biomarkers. Whole-genome gene expression microarray was performed to identify differently expressed genes between HGGs and low-grade diffuse gliomas. Several machine learning algorithms were used to filter prognostic-related genes. One hundred ninety-three HGG patients after surgical resection were selected for survival analysis. Immunohistochemistry were performed on these tumor samples to analyze IDH1 mutation status and protein expression of WEE1. qRT-PCR, western blotting, transwell assays, and scratch wound healing assays were performed to evaluate the effect of WEE1 knockdown or overexpression in HGG cells. Three prognostic-related genes (WEE1, IGF2PB3, and EMP3) were demonstrated to separate HGG patients into two different survival subgroups. The area under receiver operating characteristic curve of WEE1 was higher than that of IGF2BP3, EMP3, age, IDH status, 1p/19q status, and MGMT promoter status. WEE1 was an independent covariate compared with IDH status, age, and WHO grade. Knockdown or overexpression of WEE1 can inhibit or promote migration and invasion in U251 and U87 cell lines. WEE1, EMP3, and IGF2BP3 are reliable prognostic-related genes at the mRNA level. WEE1 is an independent prognostic biomarker in survival analysis and has potential diagnostic value for HGG patients. WEE1 can induce HGG cell migration and invasion in vitro.

摘要

我们的研究旨在建立一个更好地理解高级别神经胶质瘤(HGG)预后相关生物标志物的框架。通过全基因组基因表达微阵列来识别 HGG 与低级别弥漫性神经胶质瘤之间差异表达的基因。使用几种机器学习算法来筛选预后相关基因。选择 193 名接受手术切除后的 HGG 患者进行生存分析。对这些肿瘤样本进行免疫组织化学分析,以分析 IDH1 突变状态和 WEE1 蛋白表达。进行 qRT-PCR、western blot、transwell 分析和划痕愈合试验,以评估 WEE1 在 HGG 细胞中敲低或过表达的效果。三个预后相关基因(WEE1、IGF2PB3 和 EMP3)被证明可以将 HGG 患者分为两个不同的生存亚组。WEE1 的接受者操作特征曲线下面积高于 IGF2BP3、EMP3、年龄、IDH 状态、1p/19q 状态和 MGMT 启动子状态。与 IDH 状态、年龄和 WHO 分级相比,WEE1 是一个独立的协变量。敲低或过表达 WEE1 可以抑制或促进 U251 和 U87 细胞系的迁移和侵袭。WEE1、EMP3 和 IGF2BP3 是可靠的预后相关基因。WEE1 是生存分析中的独立预后生物标志物,对 HGG 患者具有潜在的诊断价值。WEE1 可以在体外诱导 HGG 细胞迁移和侵袭。

相似文献

1
Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma.全基因组表达微阵列结合机器学习识别高级别神经胶质瘤的预后生物标志物。
J Mol Neurosci. 2018 Apr;64(4):491-500. doi: 10.1007/s12031-018-1049-7. Epub 2018 Mar 3.
2
Expression and prognostic value of the WEE1 kinase in gliomas.WEE1激酶在胶质瘤中的表达及预后价值
J Neurooncol. 2016 Apr;127(2):381-9. doi: 10.1007/s11060-015-2050-4. Epub 2016 Jan 6.
3
Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.在 229 个人类神经胶质瘤系列中 EMP3 基因的启动子超甲基化。
Biomed Res Int. 2013;2013:756302. doi: 10.1155/2013/756302. Epub 2013 Sep 3.
4
Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma.鉴定 DNA 甲基化调控的 WEE1,其对低级别胶质瘤的预后和免疫治疗具有潜在意义。
Cancer Biomark. 2024;40(3-4):297-317. doi: 10.3233/CBM-230517.
5
Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.胶质瘤中与基因表达及异柠檬酸脱氢酶1(IDH1)突变相关的O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化位点的鉴定
Tumour Biol. 2016 Oct;37(10):13571-13579. doi: 10.1007/s13277-016-5153-4. Epub 2016 Jul 28.
6
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.IDH 1/2 突变且无 1p/19q 共缺失的 WHO Ⅲ级胶质瘤患者行全切除的影响
J Neurooncol. 2016 Sep;129(3):505-514. doi: 10.1007/s11060-016-2201-2. Epub 2016 Jul 11.
7
Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging.基于肿瘤微观侵犯范围和磁共振成像确定高级别脑胶质瘤的最佳临床靶区边界。
Radiat Oncol. 2021 Jun 7;16(1):97. doi: 10.1186/s13014-021-01819-0.
8
The prognostic role of Beclin 1 protein expression in high-grade gliomas.Beclin 1 蛋白表达在高级别胶质瘤中的预后作用。
Autophagy. 2009 Oct;5(7):930-6. doi: 10.4161/auto.5.7.9227. Epub 2009 Oct 8.
9
Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.小热休克蛋白 B11 与高级别脑胶质瘤患者 MGMT 启动子甲基化的预后价值之间的关系。
J Neurosurg. 2016 Jul;125(1):7-16. doi: 10.3171/2015.5.JNS142437. Epub 2015 Nov 6.
10
Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.抑制DNA修复基因Ercc1和Mgmt可增强替莫唑胺在胶质瘤治疗中的疗效:一项临床前研究。
Oncotarget. 2015 Oct 6;6(30):29456-68. doi: 10.18632/oncotarget.4909.

引用本文的文献

1
EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy.EMP3:一种有前途的肿瘤预后和靶向癌症治疗的生物标志物。
Cancer Biomark. 2024;40(3-4):227-239. doi: 10.3233/CBM-230504.
2
mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses.mRNA 标志物在多形性胶质母细胞瘤患者生存预测中的应用:系统评价及生物信息学分析。
BMC Cancer. 2024 May 21;24(1):612. doi: 10.1186/s12885-024-12345-z.
3
Assessing Metabolic Markers in Glioblastoma Using Machine Learning: A Systematic Review.

本文引用的文献

1
Surgical oncology for gliomas: the state of the art.脑胶质瘤的外科治疗:现状。
Nat Rev Clin Oncol. 2018 Feb;15(2):112-125. doi: 10.1038/nrclinonc.2017.171. Epub 2017 Nov 21.
2
Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma.WEE1 的激活赋予胶质母细胞瘤对 PI3K 抑制的抗性。
Neuro Oncol. 2018 Jan 10;20(1):78-91. doi: 10.1093/neuonc/nox128.
3
Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines.患者肿瘤、患者来源异种移植物和癌细胞系的分子病理学。
使用机器学习评估胶质母细胞瘤中的代谢标志物:一项系统综述。
Metabolites. 2023 Jan 21;13(2):161. doi: 10.3390/metabo13020161.
4
GlioMarker: An integrated database for knowledge exploration of diagnostic biomarkers in gliomas.GlioMarker:一个用于胶质瘤诊断生物标志物知识探索的综合数据库。
Front Oncol. 2022 Aug 11;12:792055. doi: 10.3389/fonc.2022.792055. eCollection 2022.
5
Neurosurgical Management of Cerebrospinal Tumors in the Era of Artificial Intelligence : A Scoping Review.人工智能时代脑脊液肿瘤的神经外科治疗:一项范围综述
J Korean Neurosurg Soc. 2023 Nov;66(6):632-641. doi: 10.3340/jkns.2021.0213. Epub 2022 Jul 14.
6
Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes.第二代数字健康平台:以患者为中心并聚焦临床结果。
Front Digit Health. 2020 Dec 3;2:569178. doi: 10.3389/fdgth.2020.569178. eCollection 2020.
7
Prognosis Analysis and Validation of mA Signature and Tumor Immune Microenvironment in Glioma.胶质瘤中mA特征与肿瘤免疫微环境的预后分析及验证
Front Oncol. 2020 Oct 5;10:541401. doi: 10.3389/fonc.2020.541401. eCollection 2020.
8
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target.WEE1 家族企业:调控有丝分裂、癌症进展和治疗靶标。
J Hematol Oncol. 2020 Sep 21;13(1):126. doi: 10.1186/s13045-020-00959-2.
9
Prognostic significance of age related genes in patients with lower grade glioma.低级别胶质瘤患者中年龄相关基因的预后意义
J Cancer. 2020 Apr 6;11(13):3986-3999. doi: 10.7150/jca.41123. eCollection 2020.
10
Artificial intelligence for precision medicine in neurodevelopmental disorders.用于神经发育障碍精准医学的人工智能
NPJ Digit Med. 2019 Nov 21;2:112. doi: 10.1038/s41746-019-0191-0. eCollection 2019.
Cancer Res. 2016 Aug 15;76(16):4619-26. doi: 10.1158/0008-5472.CAN-15-3245. Epub 2016 Jun 20.
4
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类:概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
5
CGCG clinical practice guidelines for the management of adult diffuse gliomas.CGCG 成人弥漫性胶质瘤治疗临床实践指南。
Cancer Lett. 2016 Jun 1;375(2):263-273. doi: 10.1016/j.canlet.2016.01.024. Epub 2016 Mar 7.
6
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.分子分析揭示弥漫性胶质瘤的生物学离散亚群和进展途径。
Cell. 2016 Jan 28;164(3):550-63. doi: 10.1016/j.cell.2015.12.028.
7
Expression and prognostic value of the WEE1 kinase in gliomas.WEE1激酶在胶质瘤中的表达及预后价值
J Neurooncol. 2016 Apr;127(2):381-9. doi: 10.1007/s11060-015-2050-4. Epub 2016 Jan 6.
8
WEE1 Kinase As a Target for Cancer Therapy.WEE1激酶作为癌症治疗的靶点。
J Clin Oncol. 2015 Oct 20;33(30):3485-7. doi: 10.1200/JCO.2015.62.2290. Epub 2015 Jul 27.
9
Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors.单药AZD1775(MK-1775),一种Wee1激酶抑制剂,用于难治性实体瘤患者的I期研究。
J Clin Oncol. 2015 Oct 20;33(30):3409-15. doi: 10.1200/JCO.2014.60.4009. Epub 2015 May 11.
10
WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.WEE1 抑制缓解了发生上皮-间充质转化的肿瘤细胞对免疫攻击的抵抗。
Cancer Res. 2014 May 1;74(9):2510-9. doi: 10.1158/0008-5472.CAN-13-1894. Epub 2014 Mar 13.